Is Now the Right Time to Buy Manulife Stock?

Manulife Financial (TSX:MFC) stock offers nice value, attractive income, and exposure to the global insurance market right now.

| More on:
investment research

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Manulife Financial (TSX:MFC) is a Toronto-based company that provides financial products and services in Canada, the United States, Asia, and around the world. Today, I want to discuss whether now is the right time to snatch up this top Canadian stock. Let’s jump in.

How has Manulife stock performed in 2022?

Shares of Manulife have dropped 6% in 2022 as of close on November 17. That has made up the bulk of its losses in the year-over-year period. However, its shares have shot up 5.9% month over month. This stock took a major hit during the sharp market pullback, stirred by the beginnings of the COVID-19 pandemic in the first half of 2020. Manulife was able to bounce back a year later, but the stock has since floundered and failed to keep up with many of its better-performing peers in the financial space.

Here’s why I’m still very excited about the insurance space

This Canadian company has carved out a strong presence in Asia. Investors should be excited about this prospect, as the middle class is experiencing tremendous growth on the continent, particularly in east Asia. In 2020, the World Economic Forum (WEF) estimated that two billion Asians were members of the middle class. It projects that number to grow to 3.5 billion by 2030. Why is this noteworthy? The middle class is a key driver for the insurance space.

In the summer, ResearchAndMarkets estimated that the global insurance market was set to grow to $5.93 trillion in 2022 compared to $5.37 trillion in 2021. Better yet, the report projects that the global insurance market will deliver a compound annual growth rate (CAGR) of 9.1% through to 2026 when the market will hit a valuation of roughly $8.39 trillion. This should spur interest in Manulife stock right now.

Should investors be pleased with Manulife’s recent earnings?

Manulife released its third-quarter fiscal 2022 earnings on November 9. It posted net income of $1.3 billion in the third quarter (Q3) 2022 — down $0.2 billion from the prior year. Meanwhile, core earnings decreased 14% on a constant exchange rate basis to $1.3 billion. The company posted Global Wealth and Asset Management net inflows of $3.0 billion, which was down from net inflows of $9.8 billion in the previous year. Like other giants in the financial space, this company has had to wrestle with a sharp increase in interest rates and choppy capital markets around the world.

ManuAcademy is a regional digital learning platform that was recently rolled out to Vietnam in the second quarter of fiscal 2022. In this most recent quarter, the company announced that it had “accelerated the utilization” of the platform. This has led to the recruitment of over 11,000 newly recruited insurance agents.

Is this stock worth buying today?

President and chief executive officer Roy Gori praised the company’s performance in the face of major economic headwinds. The company is well positioned to take advantage of the growth of the middle class in some of the fastest-growing economies in East Asia.

Shares of Manulife currently possess a very attractive price-to-earnings ratio of 6.2. It last declared a quarterly dividend of $0.33 per share. That represents a strong 5.6% yield. This stock boasts nice value, a strong dividend yield, and a bright future in a promising market. I’m looking to snatch up Manulife stock in the final weeks of November.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Investing

Investing

KM Throwaway Post

Read more »

Investing

Carlos Test Yoast Metadata

Read more »

Investing

KM Ad Test

This is my excerpt.

Read more »

Investing

Test post for affiliate partner mockups

Updated: 9/17/2024. This post was not sponsored. The views and opinions expressed in this review are purely those of the…

Read more »

Investing

Testing Ecap Error

Premium content from Motley Fool Stock Advisor We here at Motley Fool Stock Advisor believe investors should own at least…

Read more »

Investing

TSX Today: Testing the Ad for James

la la la dee dah.

Read more »

Lady holding remote control pointed towards a TV
Investing

2 Streaming Stocks to Buy Now and 1 to Run From

There are streaming stocks on the TSX that are worth paying attention to in 2023 and beyond.

Read more »

A red umbrella stands higher than a crowd of black umbrellas.
Stocks for Beginners

Top Recession-Resilient TSX Stocks to Buy With $3,000

It's time to increase your exposure to defensives!

Read more »